[Adjuvant chemotherapy of breast cancer: persistent controversy].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008408:Mastectomy; D009367:Neoplasm Staging; D011379:Prognosis
Adjuvante Chemotherapie des Mammacarcinoms: Anhaltende Kontroverse.